Nestlé Skin Health, a global leader focused on meeting the world’s increasing skin health needs, announces that the US Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft for the correction of age-related volume loss in the back of the hands for patients over the age of 21.
Restylane Lyft is the first and only HA injectable gel to be FDA-approved for restoring fullness to the back of the hands, providing more youthful-looking skin. It is also the first-ever HA dermal filler to receive FDA approval for an area other than the face.”
The Restylane Survey was conducted among 1,000 nationally representative U.S. women, ages 35+, between February 26 and March 5, 2018, using an email invitation and an online survey.
